Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2025-02-06 00:00:00 ET · period of report 2025-02-04 · accession 0000905148-25-000410 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-06 | 2025-02-04+ | RIGL | Furey Raymond J. | EVP, GC, CCO, Corp Sec | S - Sale | $21.41 | -2,787 | 40.2K | -6% | -$59.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-05 | S | D | 1,339 | $21.93 | 38,830 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-04 | S | D | 1,448 | $20.92 | 40,169 | D | — | — |